1 |
Hamblin MR, Mroz P: Advances in Photodynamic Therapy : Basic, Translational, and Clinical. Boston, Mass: Artech House; 2008.
|
2 |
Juarranz A, Jaen P, Sanz-Rodriguez F, Cuevas J, Gonzalez S: Photodynamic therapy of cancer. Basic principles and applications. Clin Transl Oncol Off Publ Federation Spanish Oncol Soc National Cancer Institute Mexico 2008, 10:148-154.
|
3 |
MacDonald IJ, Dougherty TJ: Basic principles of photodynamic therapy. J Porphyr Phthalocya 2001, 5:105-129.
DOI
|
4 |
Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q: Photodynamic therapy. J Natl Cancer Inst 1998, 90:889-905.
DOI
|
5 |
Zimcik P, Miletin M: Photodynamic therapy as a new prospective method for cancer treatment. I. History, basic principles. Ceska Slovenska Farmacie Casopis Ceske Farmaceuticke Spolecnosti Slovenske Farmaceuticke Spolecnosti 2004, 53:219-224.
|
6 |
Wilson BC: Photodynamic therapy for cancer: principles. Can J Gastroenterol J Can Gastroenterol 2002, 16:393-396.
DOI
|
7 |
Dolmans DE, Fukumura D, Jain RK: Photodynamic therapy for cancer. Nat Rev Cancer 2003, 3:380-387.
DOI
|
8 |
Sutedja TG, Postmus PE: Photodynamic therapy in lung cancer. A review. J Photochem Photobiol B 1996, 36:199-204.
DOI
|
9 |
Senior K: Photodynamic therapy for bladder cancer. Lancet oncol 2005, 6:546.
|
10 |
Biel MA: Photodynamic therapy of head and neck cancers. Methods Mol Biol 2010, 635:281-293.
DOI
|
11 |
Goff BA, Blake J, Bamberg MP, Hasan T: Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model. Br J Cancer 1996, 74:1194-1198.
DOI
|
12 |
Muschter R: Photodynamic therapy: a new approach to prostate cancer. Current Urol Reports 2003, 4:221-228.
DOI
|
13 |
Roberts DJ, Cairnduff F: Photodynamic therapy of primary skin cancer: a review. Br J Plast Surg 1995, 48:360-370.
DOI
|
14 |
Guleng GE, Helsing P: Photodynamic therapy for basal cell carcinomas in organ-transplant recipients. Clin Exp Dermatol 2012, 37:367-369.
DOI
|
15 |
Konan YN, Gurny R, Allemann E: State of the art in the delivery of photosensitizers for photodynamic therapy. J Photoch Photobio B 2002, 66:89-106.
DOI
|
16 |
Nowis D, Makowski M, Stoklosa T, Legat M, Issat T, Golab J: Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim Pol 2005, 52:339-352.
|
17 |
Milla Sanabria L, Rodriguez ME, Cogno IS, Rumie Vittar NB, Pansa MF, Lamberti MJ, Rivarola VA: Direct and indirect photodynamic therapy effects on the cellular and molecular components of the tumor microenvironment. Biochim Biophys Acta 1835, 2013:36-45.
|
18 |
Krammer B: Vascular effects of photodynamic therapy. Anticancer Res 2001, 21:4271-4277.
|
19 |
Vancikova Z: Principles of the photodynamic therapy and its impact on the immune system. Sb Lek 1998, 99:1-11.
|
20 |
Nowis D, Stoklosa T, Legat M, Issat T, Jakobisiak M, Golab J: The influence of photodynamic therapy on the immune response. Photodiagnosis Photodyn Ther 2005, 2:283-298.
DOI
|
21 |
Detty MR, Gibson SL, Wagner SJ: Current clinical and preclinical photosensitizers for use in photodynamic therapy. J Med Chem 2004, 47:3897-3915.
DOI
|
22 |
O'Connor AE, Gallagher WM, Byrne AT: Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol 2009, 85:1053-1074.
DOI
|
23 |
Ethirajan M, Chen Y, Joshi P, Pandey RK: The role of porphyrin chemistry in tumor imaging and photodynamic therapy. Chem Soc Rev 2011, 40:340-362.
DOI
|
24 |
Daicoviciu D, Filip A, Ion RM, Clichici S, Decea N, Muresan A: Oxidative photodamage induced by photodynamic therapy with methoxyphenyl porphyrin derivatives in tumour-bearing rats. Folia Biol 2011, 57:12-19.
|
25 |
Pandey RK, Bellnier DA, Smith KM, Dougherty TJ: Chlorin and porphyrin derivatives as potential photosensitizers in photodynamic therapy. Photochem Photobiol 1991, 53:65-72.
DOI
|
26 |
Spikes JD: Phthalocyanines as photosensitizers in biological systems and for the photodynamic therapy of tumors. Photochem Photobiol 1986, 43:691-699.
DOI
|
27 |
Moeno S, Krause RW, Ermilov EA, Kuzyniak W, Hopfner M: Synthesis and characterization of novel zinc phthalocyanines as potential photosensitizers for photodynamic therapy of cancers. Photochem Photobiol Sci 2014, 13:963-970.
DOI
|
28 |
Durmus M, Ahsen V: Water-soluble cationic gallium(III) and indium(III) phthalocyanines for photodynamic therapy. J Inorg Biochem 2010, 104:297-309.
DOI
|
29 |
Kreimer-Birnbaum M: Modified porphyrins, chlorins, phthalocyanines, and purpurins: second-generation photosensitizers for photodynamic therapy. Semin Hematol 1989, 26:157-173.
|
30 |
O'Neal WG, Roberts WP, Ghosh I, Wang H, Jacobi PA: Studies in chlorin chemistry. 3. A practical synthesis of c, d-ring symmetric chlorins of potential utility in photodynamic therapy. J Org Chem 2006, 71:3472-3480.
DOI
|
31 |
Vrouenraets MB, Visser GW, Snow GB, van Dongen GA: Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res 2003, 23:505-522.
|
32 |
Liebmann J, Cook JA, Mitchell JB: Cremophor EL, solvent for paclitaxel, and toxicity. Lancet 1993, 342:1428.
|
33 |
Gelderblom H, Verweij J, Nooter K, Sparreboom A: Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 2001, 37:1590-1598.
DOI
|
34 |
Derycke AS, de Witte PA: Liposomes for photodynamic therapy. Adv Drug Deliv Rev 2004, 56:17-30.
DOI
|
35 |
Broekgaarden M, de Kroon AI, Gulik TM, Heger M: Development and in vitro proof-of-concept of interstitially targeted zinc- phthalocyanine liposomes for photodynamic therapy. Curr Med Chem 2013, 21:377-391.
DOI
|
36 |
Bovis MJ, Woodhams JH, Loizidou M, Scheglmann D, Bown SG, Macrobert AJ: Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy. J Control Release 2012, 157:196-205.
DOI
|
37 |
Ricci-Junior E, Marchetti JM: Preparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc (II) phthalocyanine for photodynamic therapy use. J Microencapsul 2006, 23:523-538.
DOI
|
38 |
Ricci-Junior E, Marchetti JM: Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use. Int J Pharm 2006, 310:187-195.
DOI
|
39 |
Chatterjee DK, Fong LS, Zhang Y: Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev 2008, 60:1627-1637.
DOI
|
40 |
Lee YE, Kopelman R: Polymeric nanoparticles for photodynamic therapy. Methods Mol Biol 2011, 726:151-178.
DOI
|
41 |
Chung CW, Chung KD, Jeong YI, Kang DH: 5-aminolevulinic acid-incorporated nanoparticles of methoxy poly(ethylene glycol)-chitosan copolymer for photodynamic therapy. Int J Nanomedicine 2013, 8:809-819.
|
42 |
Taillefer J, Brasseur N, van Lier JE, Lenaerts V, Le Garrec D, Leroux JC: In-vitro and in-vivo evaluation of pH-responsive polymeric micelles in a photodynamic cancer therapy model. J Pharmacy Pharmacol 2001, 53:155-166.
DOI
|
43 |
Gibot L, Lemelle A, Till U, Moukarzel B, Mingotaud AF, Pimienta V, Saint-Aguet P, Rols MP, Gaucher M, Violleau F, Chassenieux C, Vicendo P: Polymeric micelles encapsulating photosensitizer: structure/photodynamic therapy efficiency relation. Biomacromolecules 2014, 15:1443-1455.
DOI
|
44 |
Koo H, Lee H, Lee S, Min KH, Kim MS, Lee DS, Choi Y, Kwon IC, Kim K, Jeong SY: In vivo tumor diagnosis and photodynamic therapy via tumoral pH-responsive polymeric micelles. Chem Commun (Camb) 2010, 46:5668-5670.
DOI
|
45 |
van Nostrum CF: Polymeric micelles to deliver photosensitizers for photodynamic therapy. Adv Drug Deliv Rev 2004, 56:9-16.
DOI
|
46 |
Maeda H: The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 2001, 41:189-207.
DOI
|
47 |
Nehoff H, Parayath NN, Domanovitch L, Taurin S, Greish K: Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect. Int J Nanomedicine 2014, 9:2539-2555.
|
48 |
Li F, Bae BC, Na K: Acetylated hyaluronic acid/photosensitizer conjugate for the preparation of nanogels with controllable phototoxicity: synthesis, characterization, autophotoquenching properties, and in vitro phototoxicity against HeLa cells. Bioconjug Chem 2010, 21:1312-1320.
DOI
|
49 |
Bae BC, Na K: Self-quenching polysaccharide-based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy. Biomaterials 2010, 31:6325-6335.
DOI
|
50 |
Li L, Bae BC, Tran TH, Yoon KH, Na K, Huh KM: Self-quenchable biofunctional nanoparticles of heparin-folate-photosensitizer conjugates for photodynamic therapy. Carbohyd Polym 2011, 86:708-715.
DOI
|
51 |
Oh IH, Min HS, Li L, Tran TH, Lee YK, Kwon IC, Choi K, Kim K, Huh KM: Cancer cell-specific photoactivity of pheophorbide a-glycol chitosan nanoparticles for photodynamic therapy in tumor-bearing mice. Biomaterials 2013, 34:6454-6463.
DOI
|
52 |
Kim WL, Cho H, Li L, Kang HC, Huh KM: Biarmed poly(ethylene glycol)-(pheophorbide a)2 conjugate as a bioactivatable delivery carrier for photodynamic therapy. Biomacromolecules 2014, 15:2224-2234.
DOI
|
53 |
Park W, Park SJ, Na K: The controlled photoactivity of nanoparticles derived from ionic interactions between a water soluble polymeric photosensitizer and polysaccharide quencher. Biomaterials 2011, 32:8261-8270.
DOI
|
54 |
Li L, Nurunnabi M, Nafiujjaman M, Lee YK, Huh KM: GSH-mediated photoactivity of pheophorbide a-conjugated heparin/gold nanoparticle for photodynamic therapy. J Control Release 2013, 171:241-250.
DOI
|
55 |
Li L, Md N, Md N, Jeong YY, Lee YK, Huh KM: A photosensitizer-conjugated magnetic iron oxide/gold hybrid nanoparticle as an activatable platform for photodynamic cancer therapy. J Mater Chem B 2014, 2:2929-2937.
DOI
|
56 |
Matsumura Y, Maeda H: A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986, 46:6387-6392.
|
57 |
Maeda H, Matsumura Y: Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst 1989, 6:193-210.
|
58 |
Ben-Dror S, Bronshtein I, Wiehe A, Roder B, Senge MO, Ehrenberg B: On the correlation between hydrophobicity, liposome binding and cellular uptake of porphyrin sensitizers. Photochem Photobiol 2006, 82:695-701.
DOI
|
59 |
Love WG, Duk S, Biolo R, Jori G, Taylor PW: Liposome-mediated delivery of photosensitizers: localization of zinc (II)-phthalocyanine within implanted tumors after intravenous administration. Photochem Photobiol 1996, 63:656-661.
DOI
|
60 |
Casas A, Batlle A: Aminolevulinic acid derivatives and liposome delivery as strategies for improving 5-aminolevulinic acid-mediated photodynamic therapy. Curr Med Chem 2006, 13:1157-1168.
DOI
|
61 |
Richter AM, Waterfield E, Jain AK, Canaan AJ, Allison BA, Levy JG: Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model. Photochem Photobiol 1993, 57:1000-1006.
DOI
|
62 |
Namiki Y, Namiki T, Date M, Yanagihara K, Yashiro M, Takahashi H: Enhanced photodynamic antitumor effect on gastric cancer by a novel photosensitive stealth liposome. Pharmacol Res Off J Ital Pharmacol Soc 2004, 50:65-76.
|
63 |
Sibani SA, McCarron PA, Woolfson AD, Donnelly RF: Photosensitiser delivery for photodynamic therapy. Part 2: systemic carrier platforms. Expert Opin Drug Deliv 2008, 5:1241-1254.
DOI
|
64 |
Chan JM, Valencia PM, Zhang L, Langer R, Farokhzad OC: Polymeric nanoparticles for drug delivery. Methods Mol Biol 2010, 624:163-175.
DOI
|
65 |
Veronese FM, Pasut G: PEGylation, successful approach to drug delivery. Drug Discov Today 2005, 10:1451-1458.
DOI
|
66 |
Jain A, Jain SK: PEGylation: an approach for drug delivery. A review. Crit Rev Ther Drug Carrier Syst 2008, 25:403-447.
DOI
|
67 |
Kumari A, Yadav SK, Yadav SC: Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B: Biointerfaces 2010, 75:1-18.
DOI
|
68 |
Allemann E, Brasseur N, Benrezzak O, Rousseau J, Kudrevich SV, Boyle RW, Leroux JC, Gurny R, Van Lier JE: PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours. J Pharmacy Pharmacol 1995, 47:382-387.
DOI
|
69 |
Konan YN, Berton M, Gurny R, Allemann E: Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles. Eur J Pharm Sci 2003, 18:241-249.
DOI
|
70 |
Konan YN, Cerny R, Favet J, Berton M, Gurny R, Allemann E: Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik eV 2003, 55:115-124.
|
71 |
Aliabadi HM, Lavasanifar A: Polymeric micelles for drug delivery. Expert Opin Drug Deliv 2006, 3:139-162.
DOI
|
72 |
Nishiyama N, Kataoka K: Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther 2006, 112:630-648.
DOI
|
73 |
Li B, Moriyama EH, Li F, Jarvi MT, Allen C, Wilson BC: Diblock copolymer micelles deliver hydrophobic protoporphyrin IX for photodynamic therapy. Photochem Photobiol 2007, 83:1505-1512.
DOI
|
74 |
Shieh MJ, Peng CL, Chiang WL, Wang CH, Hsu CY, Wang SJ, Lai PS: Reduced skin photosensitivity with meta-tetra(hydroxyphenyl)chlorinloaded micelles based on a poly(2-ethyl-2-oxazoline)-b-poly(d, l-lactide) diblock copolymer in vivo. Mol Pharm 2010, 7:1244-1253.
DOI
|
75 |
Knop K, Mingotaud AF, El-Akra N, Violleau F, Souchard JP: Monomeric pheophorbide(a)-containing poly(ethyleneglycol-b-epsilon-caprolactone) micelles for photodynamic therapy. Photochem Photobiol Sci 2009, 8:396-404.
DOI
|
76 |
Li L, Cho H, Yoon KH, Kang HC, Huh KM: Antioxidant-photosensitizer dual-loaded polymeric micelles with controllable production of reactive oxygen species. Int J Pharm 2014, 471:339-348.
DOI
|
77 |
Muthiah M, Park SH, Nurunnabi M, Lee J, Lee YK, Park H, Lee BI, Min JJ, Park IK: Intracellular delivery and activation of the genetically encoded photosensitizer Killer Red by quantum dots encapsulated in polymeric micelles. Colloid Surface B Biointerfaces 2014, 116:284-294.
DOI
|
78 |
Bulina ME, Chudakov DM, Britanova OV, Yanushevich YG, Staroverov DB, Chepurnykh TV, Merzlyak EM, Shkrob MA, Lukyanov S, Lukyanov KA: A genetically encoded photosensitizer. Nat Biotechnol 2006, 24:95-99.
DOI
|
79 |
Liao ZX, Li YC, Lu HM, Sung HW: A genetically-encoded KillerRed protein as an intrinsically generated photosensitizer for photodynamic therapy. Biomaterials 2014, 35:500-508.
DOI
|
80 |
Pletnev S, Gurskaya NG, Pletneva NV, Lukyanov KA, Chudakov DM, Martynov VI, Popov VO, Kovalchuk MV, Wlodawer A, Dauter Z, Pletnev V: Structural basis for phototoxicity of the genetically encoded photosensitizer KillerRed. J Biol Chem 2009, 284:32028-32039.
DOI
|
81 |
Ryumina AP, Serebrovskaya EO, Shirmanova MV, Snopova LB, Kuznetsova MM, Turchin IV, Ignatova NI, Klementieva NV, Fradkov AF, Shakhov BE, Zagaynova EV, Lukyanov KA, Lukyanov SA: Flavoprotein miniSOG as a genetically encoded photosensitizer for cancer cells. Biochim Biophys Acta 1830, 2013:5059-5067.
|
82 |
Verhille M, Couleaud P, Vanderesse R, Brault D, Barberi-Heyob M, Frochot C: Modulation of photosensitization processes for an improved targeted photodynamic therapy. Curr Med Chem 2010, 17:3925-3943.
DOI
|
83 |
Lovell JF, Liu TWB, Chen J, Zheng G: Activatable Photosensitizers for Imaging and Therapy. Chem Rev 2010, 110:2839-2857.
DOI
|
84 |
Bugaj AM: Targeted photodynamic therapy-a promising strategy of tumor treatment. Photochem Photobiol Sci 2011, 10:1097-1109.
DOI
|
85 |
McCarthy JR, Weissleder R: Model systems for fluorescence and singlet oxygen quenching by metalloporphyrins. ChemMedChem 2007, 2:360-365.
DOI
|
86 |
Lovell JF, Chen J, Jarvi MT, Cao WG, Allen AD, Liu Y, Tidwell TT, Wilson BC, Zheng G: FRET quenching of photosensitizer singlet oxygen generation. J Phys Chem B 2009, 113:3203-3211.
DOI
|
87 |
Lee SJ, Koo H, Lee DE, Min S, Lee S, Chen X, Choi Y, Leary JF, Park K, Jeong SY, Kwon IC, Kim K, Choi K: Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system. Biomaterials 2011, 32:4021-4029.
DOI
|
88 |
Gamcsik MP, Kasibhatla MS, Teeter SD, Colvin OM: Glutathione levels in human tumors. Biomarkers 2012, 17:671-691.
DOI
|